These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 8922580
1. Lack of evidence of nosocomial cross-infection by Burkholderia cepacia among Danish cystic fibrosis patients. Ryley HC, Ojeniyi B, Høiby N, Weeks J. Eur J Clin Microbiol Infect Dis; 1996 Sep; 15(9):755-8. PubMed ID: 8922580 [Abstract] [Full Text] [Related]
2. Molecular epidemiology of Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans in a cystic fibrosis center. Vu-Thien H, Moissenet D, Valcin M, Dulot C, Tournier G, Garbarg-Chenon A. Eur J Clin Microbiol Infect Dis; 1996 Nov; 15(11):876-9. PubMed ID: 8997562 [Abstract] [Full Text] [Related]
3. Identification and molecular epidemiology of nosocomial outbreaks due to Burkholderia cepacia in cystic fibrosis patients of Masih Daneshvary Hospital, Iran. Dallal MM, Telefian CF, Hajia M, Kalantar E, Dehkharghani AR, Forushani AR, Khanbabaei Q, Mobarhan M, Farzami MR. J Prev Med Hyg; 2014 Mar; 55(1):27-30. PubMed ID: 25916029 [Abstract] [Full Text] [Related]
4. Use of pulsed-field gel electrophoresis in infection control issues concerning Burkholderia cepacia. Jenney A, Liolios L, Spelman D, Russo P, Wilson J, Wesselingh S, Kotsimbos T. Infect Control Hosp Epidemiol; 2003 Aug; 24(8):624-6. PubMed ID: 12940588 [Abstract] [Full Text] [Related]
5. Burkholderia cepacia complex in cystic fibrosis and non-cystic fibrosis patients: identification of a cluster of epidemic lineages. Agodi A, Barchitta M, Gianninò V, Collura A, Pensabene T, Garlaschi ML, Pasquarella C, Luzzaro F, Sinatra F, Mahenthiralingam E, Stefani S. J Hosp Infect; 2002 Mar; 50(3):188-95. PubMed ID: 11886194 [Abstract] [Full Text] [Related]
7. Six-year molecular analysis of Burkholderia cepacia complex isolates among cystic fibrosis patients at a referral center for lung transplantation. Heath DG, Hohneker K, Carriker C, Smith K, Routh J, LiPuma JJ, Aris RM, Weber D, Gilligan PH. J Clin Microbiol; 2002 Apr; 40(4):1188-93. PubMed ID: 11923329 [Abstract] [Full Text] [Related]
8. An episodic outbreak of genetically related Burkholderia cepacia among non-cystic fibrosis patients at a university hospital. Siddiqui AH, Mulligan ME, Mahenthiralingam E, Hebden J, Brewrink J, Qaiyumi S, Johnson JA, LiPuma JJ. Infect Control Hosp Epidemiol; 2001 Jul; 22(7):419-22. PubMed ID: 11583209 [Abstract] [Full Text] [Related]
9. Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada. Speert DP, Henry D, Vandamme P, Corey M, Mahenthiralingam E. Emerg Infect Dis; 2002 Feb; 8(2):181-7. PubMed ID: 11897071 [Abstract] [Full Text] [Related]
10. Burkholderia cepacia complex in cystic fibrosis: frequency of strain replacement during chronic infection. Bernhardt SA, Spilker T, Coffey T, LiPuma JJ. Clin Infect Dis; 2003 Sep 15; 37(6):780-5. PubMed ID: 12955638 [Abstract] [Full Text] [Related]
13. Epidemiology of pulmonary colonization with Burkholderia cepacia in cystic fibrosis patients. The French Observatoire Burkholderia cepacia Study Group. Segonds C, Chabanon G, Couetdic G, Michel-Briand Y, Bingen E. Eur J Clin Microbiol Infect Dis; 1996 Oct 15; 15(10):841-2. PubMed ID: 8950569 [No Abstract] [Full Text] [Related]
14. Molecular epidemiology of Burkholderia cepacia in two Australian cystic fibrosis centres. Paul ML, Pegler MA, Benn RA. J Hosp Infect; 1998 Jan 15; 38(1):19-26. PubMed ID: 9513065 [Abstract] [Full Text] [Related]
15. Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. Pitt TL, Kaufmann ME, Patel PS, Benge LC, Gaskin S, Livermore DM. J Med Microbiol; 1996 Mar 15; 44(3):203-10. PubMed ID: 8636938 [Abstract] [Full Text] [Related]
16. Burkholderia (Pseudomonas) cepacia epidemiology in a cystic fibrosis population: a genome finger-printing study. Cazzola G, Amalfitano G, Tonolli E, Perazzoli C, Piacentini I, Mastella G. Acta Paediatr; 1996 May 15; 85(5):554-7. PubMed ID: 8827098 [Abstract] [Full Text] [Related]
17. Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status. Agodi A, Mahenthiralingam E, Barchitta M, Gianninò V, Sciacca A, Stefani S. J Clin Microbiol; 2001 Aug 15; 39(8):2891-6. PubMed ID: 11474009 [Abstract] [Full Text] [Related]
18. Exceptionally high representation of Burkholderia cepacia among B. cepacia complex isolates recovered from the major Portuguese cystic fibrosis center. Cunha MV, Pinto-de-Oliveira A, Meirinhos-Soares L, Salgado MJ, Melo-Cristino J, Correia S, Barreto C, Sá-Correia I. J Clin Microbiol; 2007 May 15; 45(5):1628-33. PubMed ID: 17360834 [Abstract] [Full Text] [Related]
19. [Burkholderia cepacia: dangers of a phytopathogen organism for patients with cystic fibrosis]. Segonds C, Chabanon G. Ann Biol Clin (Paris); 2001 May 15; 59(3):259-69. PubMed ID: 11397673 [Abstract] [Full Text] [Related]
20. Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting. Mahenthiralingam E, Campbell ME, Henry DA, Speert DP. J Clin Microbiol; 1996 Dec 15; 34(12):2914-20. PubMed ID: 8940422 [Abstract] [Full Text] [Related] Page: [Next] [New Search]